CD163 and chronic obstructive pulmonary disease: We extend these findings by showing that approximately 25% of all macrophages in human BAL fluid could not be phenotyped with CD40 and CD163 (and thus were deemed “double negative” macrophages); and that the percentage of these double negative cells increased significantly in BAL fluid of patients with COPD.